跳至主要内容
临床试验/NCT04824404
NCT04824404已完成不适用

Integrated Intervention Combining CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine

Prisma Health-Upstate1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2020年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
1
主要终点
Change in drug use

研究概览

简要总结

To conduct an 8-week pilot, randomized trial evaluating the feasibility, acceptability, and efficacy of an integrated intervention involving CBT4CBT-Buprenorphine + Recovery Coach in a population of 60 individuals who meet current DSM criteria for opioid use disorder and are receiving buprenorphine treatment in primary care.

详细描述

In this pilot study, 50 individuals with OUD on buprenorphine will be randomized to either 1) standard of care (N=25) or (2)CBT4CBT-Buprenorphine + Recovery Coach (N=250). This will be an 8-week trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •adults (≥18 years)
  • •having a DSM-V diagnosis of OUD
  • •sublingual buprenorphine/naloxone and/or buprenorphine
  • •having initiated maintenance treatment for OUD for at least 30 days before the screening
  • •self-report or toxicology screening positive for any substance within 30 days of screening;
  • •willing to accept a random assignment to either TAU/CBT4CBT-Buprenorphine + Recovery Coach;
  • •having adequate computer skills

排除标准

  • •having a severe medical or psychiatric disability that could impair their ability to perform study-related activities (determined by the clinician)
  • •being pregnant or breastfeeding;
  • •being unable to independently read and/or comprehend the consent form or other study materials
  • •being unable to read/speak English;
  • •having current suicidal ideation based on the Patient Health Questionnaire-9.

研究组 & 干预措施

Standard Treatment As Usual (TAU)

No Intervention

Participants in the standard of care condition will receive the standard treatment at the recovery program, which consists of weekly or bi-weekly visits (at the discretion of the provider) to the clinic to meet with their provider and provide a sample of blood.

CBT4CBT-Buprenorphine + Recovery Coach

Experimental

This condition will consist of the CBT4CBT-Buprenorphine intervention alongside weekly coaching sessions from a recovery professional

干预措施: CBT4CBT-Buprenorphine + Recovery Coach (Behavioral)

结局指标

主要结局

Change in drug use

时间窗: 0-8 weeks

Using saliva toxicology tests

次要结局

  • Retention to buprenorphine(3 month follow up)
  • Change in drug use(1 and 3 month follow up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

CBT4CBT-Buprenorphine + Recovery Coach for... | 临床试验